Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Activyl   
Auth. number : EU/2/10/118
INN : Indoxacarb
ATC: Anatomical main group: QP - Antiparasitic products, insecticides and repellents
Therapeutic subgroup: QP53 - Ectoparaciticides, insecticides and repellents
Pharmacological subgroup: QP53A - Ectoparasiticides for topical use, incl. insecticides
Chemical subgroup: QP53AX - Other ectoparasiticides for topical use
Chemical substance: QP53AX27 - Indoxacarb
(See WHO ATCvet Index)
Indication: For dogs and cats:
Treatment and prevention of flea infestation (Ctenocephalides felis).
The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl treated pets.
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/02/2011 Centralised - Authorisation EMEA/V/C/163 (2011)1149 of 18/02/2011
24/11/2011 Centralised - Variation EMEA/V/C/163/IB/1
Updated with Decision(2012)4065 of 11/06/2012
14/02/2012 Centralised - Variation EMEA/V/C/163/IB/2
Updated with Decision(2012)4065 of 11/06/2012
13/06/2012 Centralised - Variation (2012)4065 of 11/06/2012
22/05/2013 Centralised - Variation EMEA/V/C/163/II/3
Updated with Decision(2014)3815 of 03/06/2014
06/12/2013 Centralised - Variation EMEA/V/C/163/IB/4
Updated with Decision(2014)3815 of 03/06/2014
06/03/2014 Centralised - Variation EMEA/V/C/163/IB/5
Updated with Decision(2014)3815 of 03/06/2014
05/06/2014 Centralised - Variation (2014)3815 of 03/06/2014